Development of iminosugar-based glycosidase inhibitors as drug candidates for SARS-CoV-2 virus via molecular modelling and in vitro studies-Reference-Cited by-同舟云学术

Development of iminosugar-based glycosidase inhibitors as drug candidates for SARS-CoV-2 virus via molecular modelling and in vitro studies

Published:2023-12-12 Issue:1 Volume:39 Page:
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Ferjancic Zorana¹,Bihelovic Filip¹,Vulovic Bojan¹,Matovic Radomir²,Trmcic Milena³,Jankovic Aleksandar²,Pavlovic Milos¹,Djurkovic Filip¹,Prodanovic Radivoje¹,Djurdjevic Djelmas Aleksandra¹,Kalicanin Nevena²,Zlatovic Mario¹,Sladic Dusan¹,Vallet Thomas⁴,Vignuzzi Marco⁴⁵,Saicic Radomir N.¹⁶

Affiliation:

1. Faculty of Chemistry, University of Belgrade, Belgrade, Serbia

2. University of Belgrade-Institute of Chemistry, Technology and Metallurgy, Belgrade, Serbia

3. Innovation Centre of the Faculty of Chemistry, Belgrade, Serbia

4. Institut Pasteur, Center for the Viral Populations and Pathogenesis, Paris, France

5. A*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore

6. Serbian Academy of Sciences and Arts, Belgrade, Serbia

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link